Tag

Vaccibody

Agnete B Fredriksen

Vaccibody enters license agreement with Adaptive Biotechnologies

July 14, 2021

Vaccibody has entered into an …

Vaccibody to initiate a phase 1/2 vaccine trial

June 30, 2021

Vaccibody is initiating a phase …

Michael Engsig

Vaccibody explores potential listing on Nasdaq Global Markets in the US

March 31, 2021

Vaccibody has decided to change …

Agnete B Fredriksen

Agnete Fredriksen receives the Research Council of Norway’s innovation award

November 27, 2020

The Research Council has announced …

Agnete B Fredriksen and Michael Engsig

Vaccibody enters agreement with Genentech and accelerates R&D programs

October 1, 2020

Vaccibody has announced that it …

Michael Engsig

Vaccibody finalizes patient enrolment in Phase I/IIa trial

August 28, 2020

Vaccibody has reached the enrolment …

Agnete B Fredriksen

First patient dosed in Vaccibody and Nektar Therapeutic trial

August 21, 2020

The first patient has been …

Caspar Foghsgaard

Careers interview: An appetite for innovation

July 27, 2020

Business development in a clinical …

Michael Engsig

Vaccibody has appointed a Chief Operating Officer

August 15, 2019

The company appoints Michael Engsig, …

Martin-Bonde-vaccibody

Vaccibody moves forward with clinical study

April 10, 2017

Norwegian company Vaccibody is moving …

Profiles in Business

7648 Views

Agnete Fredriksen: “You really need to have drive to make it work”

Ellen R. Delisio

December 16, 2016

Academia and business don’t always …

vaccibody

Vaccibody completes enrolment of 12 patients for phase I/II study

March 8, 2016

Norwegian Vaccibody AS announces enrolment …

vaccibody

Vaccibody granted NOK 20 million

February 2, 2016

Vaccibody has received a grant …

Fish Vaccine Grant Issued

Ellen R. Delisio

May 27, 2015

The research collaboration “New Targeting …

vaccibody

Vaccibody completes NOK 35 million financing

July 3, 2014

Norwegian company Vaccibody has through …